
Opal Pharmaceuticals Pvt Ltd
Pharmaceutical company trading and dealing in medicines, drugs, cosmetics, and chemicals since 1983.
Pharmaceutical company trading and dealing in medicines, drugs, cosmetics, and chemicals since 1983.
Opal Pharmaceuticals Pvt Ltd (OPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 March 1983 and has a history of 41 years and 11 months. Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.56 M.
The company currently has active open charges totaling ₹4.65 Cr. The company has closed loans amounting to ₹12.31 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sohan Tambi, Manish Tambi, Kavita Tambi, and Two other members serve as directors at the Company.
Jaipur, Rajasthan, India
+91-XXXXXXXXXX
U24232RJ1983PTC002681
002681
Private Limited Indian Non-Government Company
23 Mar 1983
30 Sep 2024
31 Mar 2024
Unlisted
Roc Jaipur
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sanat Tambi ![]() | Director | 07-Jun-2021 | Current |
Sohan Tambi ![]() | Director | 23-Mar-1983 | Current |
Manish Tambi ![]() | Director | 15-Oct-1994 | Current |
Kavita Tambi ![]() | Director | 01-Apr-2017 | Current |
Meena Tambi ![]() | Director | 01-Apr-2017 | Current |
Opal Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 2.47% increase. The company also saw a substantial fall in profitability, with a 85.51% decrease in profit. The company's net worth moved up by a moderate rise of 0.8%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Opal Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sohan Tambi and Manish Tambi are mutual person
Sohan Tambi is a mutual person
Manish Tambi is a mutual person
Manish Tambi is a mutual person
Manish Tambi and Kavita Tambi are mutual person
₹46.50 M
₹123.05 M
Date | Lender | Amount | Status |
---|---|---|---|
13 Sep 2023 | Others | ₹4.50 Cr | Open |
22 Oct 2020 | Hdfc Bank Limited | ₹1.50 M | Open |
01 Jul 2020 | Others | ₹2.80 Cr | Satisfied |
24 Sep 2019 | Others | ₹2.80 Cr | Satisfied |
28 Feb 2017 | Others | ₹3.10 Cr | Satisfied |
Unlock and access historical data on people associated with Opal Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Opal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Opal Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Opal Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Opal Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur.
A charge registered on 01 Jul 2020 via Charge ID 100375481 with Others was fully satisfied on 04 Dec 2023.
A charge with Others amounted to Rs. 45.00 M with Charge ID 100796628 was registered on 13 Sep 2023.
Sanat Tambi was appointed as a Director was appointed as a Director on 07 Jun 2021 & has been associated with this company since 3 years 8 months .
A charge with Hdfc Bank Limited amounted to Rs. 1.50 M with Charge ID 100400273 was registered on 22 Oct 2020.
Opal Pharmaceuticals Pvt Ltd was incorporated on 23 Mar 1983.
The authorized share capital of Opal Pharmaceuticals Pvt Ltd is ₹ 1.50 M and paid-up capital is ₹ 0.56 M.
Currently 5 directors are associated with Opal Pharmaceuticals Pvt Ltd.
As per Ministry of Corporate Affairs (Mca), the registered address of Opal Pharmaceuticals Pvt Ltd is D-50 Hathi Babu Marg Banipark, India, Jaipur, Rajasthan, 302016.
The corporate identification number (CIN) of Opal Pharmaceuticals Pvt Ltd is U24232RJ1983PTC002681 and the company number is 002681 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Opal Pharmaceuticals Pvt Ltd has risen by 2.47%.
The financial reports for the fiscal year 2023 indicates that The net worth of Opal Pharmaceuticals Pvt Ltd has experienced an upsurge of 0.80%.
As per the financial statements for fiscal Year 2023, The total open charges for Opal Pharmaceuticals Pvt Ltd amount to ₹ 4.65 Cr.
The most recent Balance Sheet for Opal Pharmaceuticals Pvt Ltd was filed with the ROC on 31 Mar 2024.
MT
RT